Company Filing History:
Years Active: 2019
Title: Patrick Baum - Innovator in Biomarkers for IL-23A Related Diseases
Introduction
Patrick Baum is a notable inventor based in Ingelheim am Rhein, Germany. He has made significant contributions to the field of biomedical research, particularly in the development of biomarkers for the treatment of IL-23A related diseases. His work focuses on inflammatory diseases, including psoriasis, which affects millions of individuals worldwide.
Latest Patents
Patrick Baum holds 1 patent related to his innovative research. His patent, titled "Biomarkers useful in the treatment of IL-23A related diseases," outlines the use of specific biomarkers that can aid in the treatment of IL-23 related inflammatory diseases. This invention also details methods for utilizing these biomarkers in therapies that employ IL-23 antagonists, showcasing his commitment to advancing medical science.
Career Highlights
Patrick Baum is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research and development efforts. His work is instrumental in paving the way for new therapeutic options for patients suffering from inflammatory diseases.
Collaborations
Patrick has worked alongside talented colleagues, including Sudha Visvanathan and Oliver Kleiner. Their collaborative efforts enhance the research environment and foster innovation within their projects.
Conclusion
Patrick Baum's contributions to the field of biomarkers for IL-23A related diseases highlight his dedication to improving patient outcomes through innovative research. His work at Boehringer Ingelheim International GmbH exemplifies the impact of collaboration in advancing medical science.